1 results match your criteria: "Department of Clinical and Molecular Sciences (DISCLIMO). Polytechnic University of Marche Ancona[Affiliation]"
An evaluation of pharmacological options for Cushing's disease: what are the state-of-the-art options?
Expert Opin Pharmacother
April 2023
Division of Endocrinology and Metabolic Diseases, Department of Clinical and Molecular Sciences (DISCLIMO). Polytechnic University of Marche Ancona, Italy.
Introduction: Untreated Cushing's syndrome (CS) is associated with significant morbidity and mortality. Cortisol normalization is a key goal to treatment. Pituitary surgery remains the first-line approach for Cushing's disease, but sometimes it is impracticable, unsuccessful, or complicated by recurrence.
View Article and Find Full Text PDF